Fortress Biotech, Inc.'s (NASDAQ:FBIO) Shares Bounce 29% But Its Business Still Trails The Industry

Simply Wall StDec 28, 2024 20:07

Express News | Checkpoint Therapeutics Announces FDA Approval of Unloxcyt™ (Cosibelimab-Ipdl)

BreakingsDec 14, 2024 07:15

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT (Cosibelimab-ipdl)

GlobeNewswireDec 14, 2024 07:15

Fortress Solutions Names Dan Lakey as Chief Revenue Officer to Drive Strategic Growth and Strengthen FortressONE Platform

PR NewswireDec 9, 2024 22:05

Press Release: Fortress Acquires Infra Pipe Solutions, Leading Manufacturer of HDPE Pipes and Structures

Dow JonesNov 26, 2024 00:57

A. G. P. Maintains Fortress Biotech(FBIO.US) With Buy Rating, Cuts Target Price to $4

Futu NewsNov 19, 2024 16:36 · Ratings